Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant

Robert Hodgson; Joanne O'Connor; Matthew James Walton; Mousumi Biswas; Nerys Frances Woolacott

Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant

Robert Hodgson^*, Joanne O'Connor, Matthew James Walton, Mousumi Biswas, Nerys Frances Woolacott

^*Corresponding author for this work

Centre for Reviews and Dissemination

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 31 Jul 2019

Access to Document

https://www.nice.org.uk/guidance/ta591/documents/committee-papers

Cite this

Hodgson, R., O'Connor, J., Walton, M. J., Biswas, M., & Woolacott, N. F. (2019). Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ta591/documents/committee-papers

@book{61b96226272344a7bbd462f69a8deae7,

title = "Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant",

author = "Robert Hodgson and Joanne O'Connor and Walton, {Matthew James} and Mousumi Biswas and Woolacott, {Nerys Frances}",

year = "2019",

month = jul,

day = "31",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant

AU - Hodgson, Robert

AU - O'Connor, Joanne

AU - Walton, Matthew James

AU - Biswas, Mousumi

AU - Woolacott, Nerys Frances

PY - 2019/7/31

Y1 - 2019/7/31

M3 - Commissioned report

BT - Letermovir for the prophylaxis of cytomegalovirus reactivation or disease in people with seropositive-cytomegalovirus who have had an allogeneic haematopoietic stem cell transplant

PB - National Institute for Health and Care Excellence

ER -